BYAH

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Economic Moat Analysis (2026)

Invetso Score: 2/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Intangible Assets

Score: 2.0 (Weak)

BYAH’s negative TTM ROIC (-1.45%) and ROCE (-1.49%) indicate it is not converting any proprietary asset base into durable excess returns versus peers.

The absence of disclosed 5-year margin or return history limits evidence of persistent brand, IP, or regulatory advantages that would support pricing power.

With no provided metrics showing premium gross margins or superior capital efficiency, any intangible advantage appears weak relative to stronger peers in the sector.

The available data suggests customers are not paying a durable premium for differentiated assets, which is inconsistent with a strong moat.

Switching Costs

Score:

A TTM cash conversion cycle of 184.7 days suggests working-capital intensity rather than customer lock-in, which is more consistent with low switching friction than with durable retention.

Negative ROIC implies the business is not extracting recurring economic rents from installed customers, unlike peers with meaningful switching costs.

No filing-based evidence was provided of contracts, integrations, or workflow dependence that would make customers materially costly to replace.

Relative to peers with embedded software, regulated, or platform-based relationships, BYAH shows little sign of retention power that would protect margins over 5–10 years.

Network Effects

Score:

The provided metrics do not show the scale, user growth, or engagement dynamics typically required for network effects to compound versus peers.

Negative returns on capital indicate the business is not yet monetizing any ecosystem flywheel into durable profitability.

No evidence was provided of multi-sided participation, data accumulation, or platform dependency that would make the product more valuable as usage expands.

Compared with peer businesses that benefit from strong user-to-user or data-network reinforcement, BYAH appears to have no observable network moat in the supplied data.

Cost Advantage

Score:

An asset turnover of 0.51x is low and does not indicate a clear operating-cost edge versus peers that can generate more revenue per asset base.

Negative ROIC and ROCE suggest BYAH’s cost structure is not translating into superior unit economics or scale efficiency.

No evidence was provided of advantaged sourcing, manufacturing, logistics, or structural input-cost benefits that would sustain margin superiority.

Relative to lower-cost peers, the current metrics point to a business that is not yet operating with a durable cost advantage.

Efficient Scale

Score:

The available data does not indicate that BYAH serves a niche large enough to support efficient-scale protection against competition.

Negative returns on capital imply the business is not earning excess returns from a constrained market structure, which weakens the case for efficient scale.

No filing evidence was provided showing regulatory barriers, capacity constraints, or local monopoly characteristics that would limit peer entry.

Compared with peers that benefit from concentrated markets or high fixed-cost barriers, BYAH shows no clear sign of efficient-scale moat protection.

Overall Score

Score:

BYAH’s moat appears weak versus peers because the supplied metrics show negative capital returns, low asset efficiency, and no evidence of durable pricing power, switching costs, network effects, cost advantage, or efficient-scale protection.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Park Ha Biological Technology Co., Ltd. Ordinary Shares. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →